JDRF and Eli Lilly signed an agreement to fund early-stage research that could enable patients with type 1 diabetes to regenerate the insulin-producing cells destroyed by the disease. The goal of this research agreement is to understand how selected cells can be reprogrammed in order to convert them into insulin-producing cells in the body. This research is an example of regenerative medicine… Read more
The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. have agreed to to provide financial support for a clinical proof-of-concept study to investigate the effects of metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes which will be conducted at The University of Texas (UT) Southwestern Medical Center… Read more
A panel of experts convened by the FDA and NIH to try to advance research and development of the artificial pancreas put forth clinical recommendations to ensure the safe and effective testing of artificial pancreas technology in real-life situations.
The experts are in agreement that even with the advanced treatments available today… Read more
In case you didn’t see the little comment post I made after I finished the race last weekend, here’s the news: I finished the race! A few of the crew from the JDRF NW Tri Club… with medals! I fulfilled … Read more
Researchers from the University of California San Diego and GlySens Inc. have developed an implantable sensor that measures blood sugar continuously and transmits the information without wires, according to a Reuters report .
The device worked in one pig for more than a year and in another for nearly 10 months with no trouble, and the researchers hope to start a human study within a few months… Read more
The PDRC is a new state-of-the-art diabetes research and clinical center under the Department of Pediatrics at the University of California, San Diego… Read more
Biodel Inc. announced the award of two research grants by the Juvenile Diabetes Research Foundation (JDRF) to Stanford University and Oregon Health & Science University (OHSU) to evaluate the use of VIAject(R) (ultra-rapid-acting injectable human insulin) in the treatment of diabetes. The first grant will support clinical testing under the direction… Read more
The clear disparity between native, pancreatic insulin and the currently available synthetic insulins leaves a lot to be desired… Read more
Sanofi-aventis and the Juvenile Diabetes Research Foundation (JDRF) announced a unique partnership to develop therapeutic treatments for people with type 1 diabetes at different stages of the disease – both those living with the disease and the newly diagnosed – as well as preventing diabetes in those at risk… Read more
According to a Juvenile Diabetes Research Foundation (JDRF) press release, representatives from the JDRF testified this week in two congressional hearings focused on advances in diabetes research and the importance of continued diabetes research funding through the Special Diabetes Program… Read more